What We're Reading: Page 326
Industry reads hand-picked by our editors
May 06, 2016
-
Wall Street Journal
Knockoffs of Biotech Drugs Bring Paltry Savings
-
The Economist
Encore une fois
-
LA Times
'You Want a Description of Hell?' Oxycontin's 12-Hour Problem
-
Bloomberg
Glaxo’s CEO Search Will Be ‘Relatively Expensive,’ Chairman Says
May 05, 2016
May 04, 2016
-
MIT Technology Review
The World’s Most Expensive Medicine Is a Bust
-
Reuters
Biotech stock swoon sparks buyout interest: investor
-
FierceBiotech
NICE gives PTC, NHS more time to agree Duchenne drug price
-
Wall Street Journal
Videogamers Are Recruited to Fight Tuberculosis and Other Ills
May 03, 2016
May 02, 2016
Apr 29, 2016
Apr 28, 2016
-
Bloomberg
Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion
-
Wall Street Journal
Vertex Pharmaceuticals’ Cystic Fibrosis Drug Disappoints
-
Reuters
Diabetes drug test results boost Novo Nordisk
-
The Street
Sarepta Can Win Speedy FDA Drug Approval
Previous
